Compare Levi Strauss & Co. (LEVI) vs RLX Technology Inc (RLX) Price & Performance

Levi Strauss & Co. (LEVI) trades at $24.56, up 0.82% on the day, with strong analyst support (83% Buy rating) and a consensus price target of $28.00. Recent quarterly earnings have consistently beaten expectations, including a Q2 2026 EPS of $0.28 versus $0.24 expected, driven by robust direct-to-consumer growth. The company maintains solid profitability with a 61.72% gross margin and 9.66% net margin, while technical indicators show a bearish overall signal despite bullish moving averages.

The outlook is positive given earnings momentum and raised full-year guidance, though near-term stock performance faces headwinds from tariff concerns and foreign exchange pressures. Investment appeal lies in its digital strategy execution and dividend growth, with risks including competitive pressures and macroeconomic volatility affecting consumer spending.

RLX trades at $2.06, up 0.49% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q1 2026 revenue growth driven by international expansion, with 2025 net income of $921.87M and a net margin of 22.47%. Recent news highlights the company's cash-rich, debt-free position and its positioning in the growing global vaping market.

The outlook is mixed; strong fundamentals and market growth potential are offset by consecutive earnings misses and a single analyst's hold rating. Key risks include regulatory scrutiny in the vaping industry and execution challenges in international expansion. The stock presents a speculative opportunity for investors comfortable with sector-specific regulatory risks.